Related Experiment Video
Updated: Jul 20, 2025

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
A-to-I RNA editing shows dramatic up-regulation in osteosarcoma and broadly regulates tumor-related genes by altering
Fuqun Ge1, Xinyue Cao2, Yankai Jiang3
1Department of Joint Surgery, The Second Hospital of Shandong University, Jinan, 250033, Shandong, China.
Abstract:
A-to-I RNA editing is a prevalent type of RNA modification in animals. The dysregulation of RNA editing has led to multiple human cancers. However, the role of RNA editing has never been studied in osteosarcoma, a complex bone cancer with unknown molecular basis. We retrieved the RNA-sequencing data from 24 primary osteosarcoma patients and 3 healthy controls. We systematically profiled the RNA editomes in these samples and quantitatively identified reliable differential editing sites (DES) between osteosarcoma and normal samples. RNA editing efficiency is dramatically increased in osteosarcoma, presumably due to the significant up-regulation of editing enzymes ADAR1 and ADAR2. Up-regulated DES in osteosarcoma are enriched in 3'UTRs. Strikingly, such 3'UTR sites are further enriched in microRNA binding regions of gene EMP2 and other oncogenes, abolishing the microRNA suppression on target genes. Accordingly, the expression of these tumor-promoting genes is elevated in osteosarcoma. There might be an RNA editing-dependent pathway leading to osteosarcoma. We expanded our knowledge on the potential roles of RNA editing in oncogenesis. Based on these molecular features, our work is valuable for future prognosis and diagnosis of osteosarcoma.
Insights
RNA editing efficiency significantly increases in osteosarcoma, driven by elevated ADAR1/ADAR2 enzymes. This dysregulation impacts microRNA binding sites, potentially driving oncogenesis and offering new diagnostic avenues for this bone cancer.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- A-to-I RNA editing is a crucial post-transcriptional modification in animals.
- Dysregulation of RNA editing is implicated in various human cancers.
- The role of RNA editing in osteosarcoma remains unexplored.
Purpose of the Study:
- To investigate the role and impact of RNA editing in osteosarcoma.
- To identify differential RNA editing sites (DES) between osteosarcoma and normal tissues.
- To explore the functional consequences of altered RNA editing in osteosarcoma oncogenesis.
Main Methods:
- Analysis of RNA-sequencing data from 24 primary osteosarcoma patients and 3 healthy controls.
- Systematic profiling of RNA editomes to identify differential editing sites (DES).
- Quantitative analysis of RNA editing efficiency and enzyme expression (ADAR1, ADAR2).
Main Results:
- Osteosarcoma exhibits dramatically increased RNA editing efficiency.
- Significant upregulation of ADAR1 and ADAR2 enzymes observed in osteosarcoma.
- Differential editing sites (DES) are enriched in 3'UTRs, particularly in microRNA binding regions of oncogenes like EMP2.
- Upregulated DES abolish microRNA suppression, leading to elevated expression of tumor-promoting genes.
Conclusions:
- RNA editing plays a significant role in osteosarcoma development.
- An RNA editing-dependent pathway may contribute to osteosarcoma oncogenesis.
- Findings provide valuable molecular insights for potential osteosarcoma prognosis and diagnosis.
Related Concept Videos
MicroRNAs
RNA Editing
Experimental RNAi
Regulation of Expression at Multiple Steps
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

